Rogier W. Rooswinkel
- Molecular Biology
- Oncology top 10%
- Immunology
- Epidemiology
- Pharmacology top 5%
- Co-authors
- Bert van de KooijMarcel VerheijJannie BorstRobert A.B. van WaterschootAlfred H. SchinkelAntonius E. van HerwaardenShafiq U. AhmedM. Eugenia Delgado
- Topics
- Cell death mechanisms and regulation (7 papers)Drug Transport and Resistance Mechanisms (3 papers)RNA Interference and Gene Delivery (3 papers)
- Partner nations
- NetherlandsUnited StatesSlovakia
In The Last Decade
Rogier W. Rooswinkel
14 papers receiving 771 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 509
- Oncology 262
- Immunology 156
- Epidemiology 108
- Pharmacology 98
Countries citing papers authored by Rogier W. Rooswinkel
This map shows the geographic impact of Rogier W. Rooswinkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogier W. Rooswinkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogier W. Rooswinkel more than expected).
Fields of papers citing papers by Rogier W. Rooswinkel
This network shows the impact of papers produced by Rogier W. Rooswinkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogier W. Rooswinkel. The network helps show where Rogier W. Rooswinkel may publish in the future.
Co-authorship network of co-authors of Rogier W. Rooswinkel
This figure shows the co-authorship network connecting the top 25 collaborators of Rogier W. Rooswinkel. A scholar is included among the top collaborators of Rogier W. Rooswinkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rogier W. Rooswinkel. Rogier W. Rooswinkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 7 | |
| 3 | 3 | |
| 4 | 336 | |
| 5 | 1 | |
| 6 | 83 | |
| 7 | 18 | |
| 8 | Targeting anti-apoptotic BCL-2 proteins in cancer: the importance of intermolecular interactions and protein turnover | 1 |
| 9 | 74 | |
| 10 | 23 | |
| 11 | 85 | |
| 12 | 50 | |
| 13 | 54 | |
| 14 | 41 |
About Rogier W. Rooswinkel
Rogier W. Rooswinkel is a scholar working on Pharmacology, Management of Technology and Innovation and Oncology, having authored 14 papers that have together received 781 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (7 papers), Drug Transport and Resistance Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Pharmacology (98 citations), Oncology (262 citations) and Molecular Biology (509 citations). Rogier W. Rooswinkel has collaborated with scholars based in Netherlands, United States and Slovakia. Frequent co-authors include Bert van de Kooij, Marcel Verheij, Jannie Borst, Robert A.B. van Waterschoot, Alfred H. Schinkel, Antonius E. van Herwaarden, Shafiq U. Ahmed, M. Eugenia Delgado, Andrew Oberst and Jos H. Beijnen. Their work appears in journals such as Blood, Nature Biotechnology and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.